STAT3-IN-36

Overview

STAT3-IN-36 (compound 11g) is a triple-target inhibitor targeting LRPPRC , STAT3 , and CDK1 with anticancer activity. STAT3-IN-36 binds to LRPPRC, STAT3 , and CDK1 , exerting a stronger anticancer effect than TMF ( HY-N6818 ) or Capecitabine ( HY-B0016 ). STAT3-IN-36 inhibits HGC27 cells with IC 50 1.8 μM..

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Signaling Pathways > STAT

Product Information

• Catalog No.: HY-168519
• CAS No.: 3055766-74-7
• Molecular Formula: C30H24F2N2O9S2
• Molecular Weight: 658.65
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source